A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Pharmacy costs and outpatient facility care generate 69% of the cost increase for 2025, according to Milliman’s recent Medical Index.

Jason R. Smith, Pharm.D., appointed as chief pharmacy officer in February 2025 for the University of Rochester Medical Center ...

A growing trend towards pharmaceutical outpatient treatment spending is driven by accessibility, according to Eric Tichy, ...

In a conversation with Managed Healthcare Executive, Hunter expressed that work requirements are an effective way to manage Medicaid eligibility, but what is proposed will cause more harm to those who ...